Bristol-Myers Squibb (BMY) Misses Q4 EPS by 4c; Guides Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Jefferies; Says Takeover 'Increasingly Likely'
January 27, 2017 8:26 AM ESTJefferies analyst Jeffrey Holford lowered estimates and his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $69.00) but said a takeover increasingly likely as the stock moves towards our ex-lung valuation of $44.
Holford commented, "Management seems to have scared investors... More
Bristol-Myers Squibb (BMY) Extends Losses Mid-Day
January 26, 2017 12:44 PM ESTBristol-Myers Squibb (NYSE: BMY) is seeing notable mid-day weakness following results this morning. The company's earnings call has already ended. Shares are down 4.4%.
... More